Riken Corporation

Juntendo Educational Foundation

Fujitsu Corporation

Kaoru Mogushi

Masahiro Kataoka

Yoshihide Hayashizaki

Ryo Matsumura

Masayoshi Ito

Hideya Kawaji

Kenji Suzuki

Hiroko Oomiya

Tsuyoshi Saito

Yasunari Yamanaka

Kieko Hara

Kazuya Takamochi

Keiko Mitani

Provided is an approach for differentially determining the histological type of a lung cancer lesion objectively and rapidly with high accuracy. A method for differentially assessing a lesion in a lung cancer patient as squamous cell carcinoma or adenocarcinoma, comprising a step of measuring an expression level of an expression product of at least one DNA comprising a transcription start site in a biological sample collected from the lesion, wherein the DNA comprises a base at an arbitrary position in the transcription start site and at least one or more bases located immediately downstream thereof in any of nucleotide sequences represented by SEQ ID NOs: 1 to 213, and the transcription start site is a region wherein both ends thereof are defined by the first base and the 101st base counted from the 3' end in any of the nucleotide sequences represented by SEQ ID NOs: 1 to 213.

Method for differentiating between lung squamous cell carcinoma and lung adenocarcinoma

Growing community of inventors

Bunkyo-ku, Japan

Kaoru Mogushi